Intraocular Lens Calculation Using Artificial Intelligence
1 other identifier
observational
170
1 country
1
Brief Summary
The aim of this study is to investigate the lens diameter (LD) as a useful parameter in intraocular lens (IOL) power calculation by using several different non-invasive imaging techniques. The aim is to establish an accurate model for lens diameter estimation and subsequently evaluate the influence of the LD on the effective postoperative lens position. The comparability of the different devices in terms of variability between the biometric measurements will also be assessed. By then combining these two approaches with artificial intelligence, the aim is to develop a new approach to effectively incorporate the LD in IOL power calculation and improve patient's outcome in the long run.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2025
CompletedFirst Posted
Study publicly available on registry
October 2, 2025
CompletedStudy Start
First participant enrolled
November 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2028
October 2, 2025
October 1, 2025
1.7 years
September 23, 2025
October 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Prediction model to estimate lens diameter with different measurement tools (swept-AS segment OCT; anterior segment-OCT and Placido topography with OCT-based anterior segment tomography; wave-front abberometry; swept-source OCT and optical biometer)
Developing a prediction model to accurately estimate the lens diameter using biometric parameters (swept-source anterior segment Optical Coherence Topography (Casia-2), Placido topography combined with Optical Coherenece Topography-based anterior segment tomography (MS-39), wave-front abberometry (OSIRIS), Swept-Source Optical Coherence Tomography (IOLMaster 700) and anterior segment swept-source OCT (Anterion).
preoperatively, 4 and 12 weeks post cataract surgery
Prediction model to estimate lens diameter with cerebral Magnetic Resonance Imaging
Developing a prediction model to accurately estimate the lens diameter using cerebral Magnetic Resonance Imaging to examine ocular configuration
12 weeks post cataract surgery
Secondary Outcomes (2)
IOL calculation concept an artificial intelligence approach
preoperatively, 4 and 12 weeks post cataract surgery
Different measurement modalities for the biometry of the eye
4 and 12 weeks post cataract surgery
Study Arms (2)
Study Cohort with MRI
Patients who are included in this study who additionally receive a cerebral MRI
Study cohort without MRI
Study cohort who doesn't receive an MRI
Interventions
Device: Swept-Source Anterior Segment OCT The CASIA-2 (Tomey, Japan) is a high-resolution swept-source anterior segment OCT with CE certification. The device allows for incomplete visualization of the lens, including the anterior and posterior lens curvature. Device: AS-OCT + Placido disc corneal topography The MS-39 (CSO, Italy) is a non-invasive device that combines Placido topography with OCT-based anterior segment tomography. Device: Wave-front abberomtery The OSIRIS aberrometer is a standard tool for examining corneal aberration and measuring the ocular wavefront. Device: Swept-Source OCT The IOLMaster 700 (Carl Zeiss Meditec, Germany) is a standard swept-source OCT used for eye examinations. Device: AS-OCT The ANTERION (Heidelberg Engineering, Germany) is an anterior segment swept-source OCT. Diagnostic Test: Refraction Subjective Refraction evaluation using the cross-cylinder method
Eligibility Criteria
The participants will be selected at Kepler University Clinic Linz at the Departement of Ophthalmology and Optometry.
You may qualify if:
- age 21 years and older
- planned uncomplicated bilateral cataract surgery
- availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits
- ability to consent to the participation in the study
- signed informed consent
You may not qualify if:
- multifocal IOL
- combined surgery (cataract plus glaucoma/vitreoretinal/corneal surgery)
- PEX, previous ocular surgery, severe trauma or any pathology that could lead to an unstable capsular bag
- glaucoma or any other retinal disease that may affect visual acuity significantly
- pregnancy
- pre-operative visual acuity below 0.1 Snellen decimal (1.0 Log MAR)
- pupil diameter \<4mm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kepler University Clinic, Linz
Linz, 4020, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nino Hirnschall, MD PhD
JKU Linz
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2025
First Posted
October 2, 2025
Study Start
November 1, 2025
Primary Completion (Estimated)
July 30, 2027
Study Completion (Estimated)
October 30, 2028
Last Updated
October 2, 2025
Record last verified: 2025-10